Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126, 663–676 (2006). ArticleCASPubMed Google Scholar
Brambrink, T. et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell2, 151–159 (2008). ArticleCASPubMedPubMed Central Google Scholar
Stadtfeld, M., Maherali, N., Breault, D. & Hochedlinger, K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell2, 230–240 (2008). ArticleCASPubMedPubMed Central Google Scholar
Maherali, N. et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell1, 55–70 (2007). ArticleCASPubMed Google Scholar
Nakagawa, M. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnol.26, 101–106 (2008). ArticleCAS Google Scholar
Wernig, M., Meissner, A., Cassady, J. & Jaenisch, R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell2, 10–12 (2008). ArticleCASPubMed Google Scholar
Mansour, A. A. et al. The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming. Nature488, 409–413 (2012). ArticleADSCASPubMed Google Scholar
Buganim, Y. et al. Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell150, 1209–1222 (2012). This study performed the first single cell transcriptional analysis of nascent iPSCs and identified an early stochastic and a late deterministic phase. ArticleCASPubMedPubMed Central Google Scholar
Shu, J. et al. Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell153, 963–975 (2013). This report demonstrated that iPSCs can be derived through ectopic expression of lineage specifiers rather than conventional pluripotency factors. ArticleCASPubMedPubMed Central Google Scholar
Loh, K. M. & Lim, B. A precarious balance: pluripotency factors as lineage specifiers. Cell Stem Cell8, 363–369 (2011). ArticleCASPubMed Google Scholar
Hikichi, T. et al. Transcription factors interfering with dedifferentiation induce cell type-specific transcriptional profiles. Proc. Natl Acad. Sci. USA110, 6412–6417 (2013). ArticleADSCASPubMedPubMed Central Google Scholar
Gifford, C. A. et al. Transcriptional and epigenetic dynamics during specification of human embryonic stem cells. Cell153, 1149–1163 (2013). ArticleCASPubMedPubMed Central Google Scholar
Xie, W. et al. Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell153, 1134–1148 (2013). References 20 and 21 established comprehensive chromatin and DNA methylation maps of pluripotent and diverse lineage-restricted cells. ArticleCASPubMedPubMed Central Google Scholar
Koche, R. P. et al. Reprogramming factor expression initiates widespread targeted chromatin remodeling. Cell Stem Cell8, 96–105 (2011). ArticleCASPubMedPubMed Central Google Scholar
Soufi, A., Donahue, G. & Zaret, K. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell151, 994–1004 (2012). This publication determined how somatic chromatin structure influences access by reprogramming factors and identified important barriers to iPSC formation. ArticleCASPubMedPubMed Central Google Scholar
Wen, B., Wu, H., Shinkai, Y., Irizarry, R. A. & Feinberg, A. P. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nature Genet.41, 246–250 (2009). ArticleCASPubMed Google Scholar
Bernstein, B. E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell125, 315–326 (2006). ArticleCASPubMed Google Scholar
Jia, J. et al. Regulation of pluripotency and self- renewal of ESCs through epigenetic-threshold modulation and mRNA pruning. Cell151, 576–589 (2012). ArticleCASPubMedPubMed Central Google Scholar
Wang, T. et al. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell9, 575–587 (2011). ArticleCASPubMed Google Scholar
Zhao, W. et al. Jmjd3 inhibits reprogramming by upregulating expression of INK4a/Arf and targeting PHF20 for ubiquitination. Cell152, 1037–1050 (2013). ArticleCASPubMedPubMed Central Google Scholar
Liang, G., He, J. & Zhang, Y. Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming. Nature Cell Biol.14, 457–466 (2012). ArticleCASPubMed Google Scholar
Chen, J. et al. H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nature Genet.45, 34–42 (2013). ArticleCASPubMed Google Scholar
Sridharan, R. et al. Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1γ in reprogramming to pluripotency. Nature Cell Biol.15, 872–882 (2013). Reports 36 and 37 identified H3K9 methylation as a major chromatin barrier of cellular reprogramming into iPSCs. ArticleCASPubMed Google Scholar
Ang, Y. S. et al. Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell145, 183–197 (2011). ArticleCASPubMedPubMed Central Google Scholar
Esch, D. et al. A unique Oct4 interface is crucial for reprogramming to pluripotency. Nature Cell Biol.15, 295–301 (2013). ArticleCASPubMed Google Scholar
Pawlak, M. & Jaenisch, R. De novo DNA methylation by Dnmt3a and Dnmt3b is dispensable for nuclear reprogramming of somatic cells to a pluripotent state. Genes Dev.25, 1035–1040 (2011). ArticleCASPubMedPubMed Central Google Scholar
Gao, Y. et al. Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell12, 453–469 (2013). ArticleCASPubMed Google Scholar
de Laat, W. & Duboule, D. Topology of mammalian developmental enhancers and their regulatory landscapes. Nature502, 499–506 (2013). ArticleADSCASPubMed Google Scholar
Skene, P. J. & Henikoff, S. Histone variants in pluripotency and disease. Development140, 2513–2524 (2013). ArticleCASPubMed Google Scholar
Gaspar-Maia, A. et al. MacroH2A histone variants act as a barrier upon reprogramming towards pluripotency. Nature Commun.4, 1565 (2013). ArticleADSCAS Google Scholar
Pasque, V. et al. Histone variant macroH2A marks embryonic differentiation in vivo and acts as an epigenetic barrier to induced pluripotency. J. Cell Sci.125, 6094–6104 (2012). ArticleCASPubMedPubMed Central Google Scholar
Barrero, M. J. et al. Macrohistone variants preserve cell identity by preventing the gain of H3K4me2 during reprogramming to pluripotency. Cell Rep.3, 1005–1011 (2013). ArticleCASPubMed Google Scholar
Singhal, N. et al. Chromatin-remodeling components of the BAF complex facilitate reprogramming. Cell141, 943–955 (2010). ArticleCASPubMed Google Scholar
Luo, M. et al. NuRD Blocks reprogramming of mouse somatic cells into pluripotent stem cells. Stem Cells31, 1278–1286 (2013). ArticleCASPubMed Google Scholar
Rais, Y et al. Deterministic direct reprogramming of somatic cells to pluipotency. Naturehttp://dx.doi.org/10.1038/nature12587 (18 September 2013). This study reports that the depletion of the NURD component Mbd3 during iPSC induction is sufficient to render reprogramming a deterministic process.
Yildirim, O. et al. Mbd3/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells. Cell147, 1498–1510 (2011). ArticleCASPubMedPubMed Central Google Scholar
Peric-Hupkes, D. et al. Molecular maps of the reorganization of genome-nuclear lamina interactions during differentiation. Mol. Cell38, 603–613 (2010). ArticleCASPubMedPubMed Central Google Scholar
Phillips-Cremins, J. E. et al. Architectural protein subclasses shape 3D organization of genomes during lineage commitment. Cell153, 1281–1295 (2013). ArticleCASPubMedPubMed Central Google Scholar
Apostolou, E. et al. Genome-wide chromatin interactions of the Nanog locus in pluripotency, differentiation, and reprogramming. Cell Stem Cell12, 699–712 (2013). ArticleCASPubMedPubMed Central Google Scholar
Wei, Z. et al. Klf4 organizes long-range chromosomal interactions with the Oct4 locus in reprogramming and pluripotency. Cell Stem Cell13, 36–47 (2013). ArticleCASPubMed Google Scholar
Zhang, H. et al. Intrachromosomal looping is required for activation of endogenous pluripotency genes during reprogramming. Cell Stem Cell13, 30–35 (2013). References 61–63 identified pluripotency-specific, genome-wide interaction networks around pluripotency loci and implicate mediator and cohesin in their regulation. ArticleCASPubMed Google Scholar
Levasseur, D. N., Wang, J., Dorschner, M., Stamatoyannopoulos, J. & Orkin, S. Oct4 dependence of chromatin structure within the extended Nanog locus in ES cells. Genes Dev.22, 575–580 (2008). ArticleCASPubMedPubMed Central Google Scholar
Schoenfelder, S. et al. Preferential associations between co-regulated genes reveal a transcriptional interactome in erythroid cells. Nature Genet.42, 53–61 (2010). ArticleCASPubMed Google Scholar
Whyte, W. A. et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell153, 307–319 (2013). ArticleCASPubMedPubMed Central Google Scholar
Ichida, J. K. et al. A small-molecule inhibitor of Tgf-β signaling replaces Sox2 in reprogramming by inducing Nanog. Cell Stem Cell5, 491–503 (2009). ArticleCASPubMedPubMed Central Google Scholar
Maherali, N. & Hochedlinger, K. Tgfβ signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr. Biol.19, 1718–1723 (2009). ArticleCASPubMedPubMed Central Google Scholar
Ho, L. et al. esBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb function. Nature Cell Biol.13, 903–913 (2011). ArticleCASPubMed Google Scholar
Leitch, H. G. et al. Naive pluripotency is associated with global DNA hypomethylation. Nature Struct. Mol. Biol.20, 311–316 (2013). ArticleCAS Google Scholar
Yamaji, M. et al. PRDM14 ensures naive pluripotency through dual regulation of signaling and epigenetic pathways in mouse embryonic stem cells. Cell Stem Cell12, 368–382 (2013). References 71 and 72 characterize the effect of combined Gsk3/Mapk signal inhibition ('2i') on the epigenome of ES cells and provide an intriguing link to Prdm14. ArticleCASPubMed Google Scholar
Ho, R., Papp, B., Hoffman, J. A., Merrill, B. J. & Plath, K. Stage-specific regulation of reprogramming to induced pluripotent stem cells by wnt signaling and T cell factor proteins. Cell Rep.3, 2113–2126 (2013). ArticleCASPubMedPubMed Central Google Scholar
Esteban, M. A. et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell6, 71–79 (2010). ArticleCASPubMed Google Scholar
Stadtfeld, M. et al. Ascorbic acid prevents loss of Dlk1–Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. Nature Genet.44, 398–405 (2012). ArticleCASPubMed Google Scholar
Hansson, J. et al. Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency. Cell Rep.2, 1579–1592 (2012). ArticleCASPubMedPubMed Central Google Scholar
Tanabe, K., Nakamura, M., Narita, M., Takahashi, K. & Yamanaka, S. Maturation, not initiation, is the major roadblock during reprogramming toward pluripotency from human fibroblasts. Proc. Natl Acad. Sci. USA110, 12172–12179 (2013). ArticleADSCASPubMedPubMed Central Google Scholar
Golipour, A. et al. A late transition in somatic cell reprogramming requires regulators distinct from the pluripotency network. Cell Stem Cell11, 769–782 (2012). ArticleCASPubMed Google Scholar
Hou, P. et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science341, 651–654 (2013). This provocative report suggests that induced pluripotency can be achieved with four small compounds and without the use of transcription factors. ArticleADSCASPubMed Google Scholar
Egli, D. et al. Reprogramming within hours following nuclear transfer into mouse but not human zygotes. Nature Commun.2, 488 (2011). ArticleADSCAS Google Scholar
Gu, T. P. et al. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature477, 606–610 (2011). ArticleADSCASPubMed Google Scholar
Wu, G. et al. Establishment of totipotency does not depend on Oct4A. Nature Cell Biol.15, 1089–1097 (2013). The authors of this study discovered that Oct4 is dispensable for reprogramming somatic nuclei by SCNT, which pointed to important mechanistic differences with induced pluripotency. ArticleCASPubMed Google Scholar
Maekawa, M. et al. Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature474, 225–229 (2011). ArticleCASPubMed Google Scholar
Jullien, J., Astrand, C., Halley-Stott, R. P., Garrett, N. & Gurdon, J. B. Characterization of somatic cell nuclear reprogramming by oocytes in which a linker histone is required for pluripotency gene reactivation. Proc. Natl Acad. Sci. USA107, 5483–5488 (2010). ArticleADSCASPubMedPubMed Central Google Scholar
Yang, S. M., Kim, B. J., Norwood Toro, L. & Skoultchi, A. I. H1 linker histone promotes epigenetic silencing by regulating both DNA methylation and histone H3 methylation. Proc. Natl Acad. Sci. USA110, 1708–1713 (2013). ArticleADSCASPubMedPubMed Central Google Scholar
Nashun, B., Akiyama, T., Suzuki, M. G. & Aoki, F. Dramatic replacement of histone variants during genome remodeling in nuclear-transferred embryos. Epigenetics6, 1489–1497 (2011). ArticleCASPubMed Google Scholar
Jullien, J. et al. HIRA dependent H3.3 deposition is required for transcriptional reprogramming following nuclear transfer to Xenopus oocytes. Epigenetics Chromatin5, 17 (2012). ArticleCASPubMedPubMed Central Google Scholar
Pasque, V., Gillich, A., Garrett, N. & Gurdon, J. B. Histone variant macroH2A confers resistance to nuclear reprogramming. EMBO J.30, 2373–2387 (2011). ArticleCASPubMedPubMed Central Google Scholar
Han, D. W. et al. Pluripotential reprogramming of the somatic genome in hybrid cells occurs with the first cell cycle. Stem Cells26, 445–454 (2008). ArticleCASPubMed Google Scholar
Piccolo, F. M. et al. Different roles for Tet1 and Tet2 proteins in reprogramming-mediated erasure of imprints induced by EGC fusion. Mol. Cell49, 1023–1033 (2013). ArticleCASPubMedPubMed Central Google Scholar
Pereira, C. F. et al. Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2. PLoS Genet.4, e1000170 (2008). ArticlePubMedPubMed CentralCAS Google Scholar
Do, J. T. et al. Enhanced reprogramming of Xist by induced upregulation of Tsix and Dnmt3a. Stem Cells26, 2821–2831 (2008). ArticleCASPubMed Google Scholar
Foshay, K. M. et al. Embryonic stem cells induce pluripotency in somatic cell fusion through biphasic reprogramming. Mol. Cell46, 159–170 (2012). ArticleCASPubMedPubMed Central Google Scholar
Ma, D. K., Chiang, C. H., Ponnusamy, K., Ming, G. L. & Song, H. G9a and Jhdm2a regulate embryonic stem cell fusion-induced reprogramming of adult neural stem cells. Stem Cells26, 2131–2141 (2008). ArticleCASPubMedPubMed Central Google Scholar
Pereira, C. F. et al. ESCs require PRC2 to direct the successful reprogramming of differentiated cells toward pluripotency. Cell Stem Cell6, 547–556 (2010). ArticleCASPubMed Google Scholar
Hajkova, P. et al. Chromatin dynamics during epigenetic reprogramming in the mouse germ line. Nature452, 877–881 (2008). ArticleADSCASPubMed Google Scholar
Magnúsdóttir, E., Gillich, A., Grabole, N. & Surani, M. A. Combinatorial control of cell fate and reprogramming in the mammalian germline. Curr. Opin. Genet. Dev.22, 466–474 (2012). ArticlePubMedCAS Google Scholar
Sachs, M. et al. Bivalent chromatin marks developmental regulatory genes in the mouse embryonic germline in vivo. Cell Rep.3, 1777–1784 (2013). ArticleCASPubMedPubMed Central Google Scholar
Durcova-Hills, G., Tang, F., Doody, G., Tooze, R. & Surani, M. A. Reprogramming primordial germ cells into pluripotent stem cells. PLoS ONE3, e3531 (2008). ArticleADSPubMedPubMed CentralCAS Google Scholar
Krentz, A. D. et al. The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency. Proc. Natl Acad. Sci. USA106, 22323–22328 (2009). ArticleADSCASPubMedPubMed Central Google Scholar
Hackett, J. A. et al. Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. Science339, 448–452 (2013). ArticleADSCASPubMed Google Scholar
Dawlaty, M. M. et al. Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development. Dev. Cell24, 310–323 (2013). ArticleCASPubMedPubMed Central Google Scholar
Kagiwada, S., Kurimoto, K., Hirota, T., Yamaji, M. & Saitou, M. Replication-coupled passive DNA demethylation for the erasure of genome imprints in mice. EMBO J.32, 340–353 (2013). ArticleCASPubMed Google Scholar
Eminli, S. et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nature Genet.41, 968–976 (2009). ArticleCASPubMed Google Scholar
Tan, K. Y., Eminli, S., Hettmer, S., Hochedlinger, K. & Wagers, A. J. Efficient generation of iPS cells from skeletal muscle stem cells. PLoS ONE6, e26406 (2011). ArticleADSCASPubMedPubMed Central Google Scholar
Barker, N. et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature457, 608–611 (2009). ArticleADSCASPubMed Google Scholar
Folmes, C. D. et al. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab.14, 264–271 (2011). ArticleCASPubMedPubMed Central Google Scholar
Suvà, M. L., Riggi, N. & Bernstein, B. E. Epigenetic reprogramming in cancer. Science339, 1567–1570 (2013). ArticleADSPubMedCAS Google Scholar
He, J., Nguyen, A. T. & Zhang, Y. KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia. Blood117, 3869–3880 (2011). ArticleCASPubMedPubMed Central Google Scholar
Tzatsos, A. et al. KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs. J. Clin. Invest.123, 727–739 (2013). CASPubMedPubMed Central Google Scholar
Gaudet, F. et al. Induction of tumors in mice by genomic hypomethylation. Science300, 489–492 (2003). ArticleADSCASPubMed Google Scholar
Moran-Crusio, K. et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell20, 11–24 (2011). ArticleCASPubMedPubMed Central Google Scholar
Kadoch, C. et al. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nature Genet.45, 592–601 (2013). ArticleCASPubMed Google Scholar
Doi, A. et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nature Genet.41, 1350–1353 (2009). ArticleCASPubMed Google Scholar
Stricker, S. H. et al. Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner. Genes Dev.27, 654–669 (2013). ArticleCASPubMedPubMed Central Google Scholar
Rapino, F. et al. C/EBPα induces highly efficient macrophage transdifferentiation of B lymphoma and leukemia cell lines and impairs their tumorigenicity. Cell Rep.3, 1153–1163 (2013). ArticleCASPubMed Google Scholar